TY - CONF
T1 - Vascular damaging activity and tumor growth inhibition of ZD6126 in combination with paclitaxel.
JO - CLINICAL CANCER RESEARCH
PY - 2005/01/01
AU - Martinelli M
AU - Riccardi E
AU - Zucchetti M
AU - Ryan A
AU - Taraboletti G
AU - Giavazzi R
ED -
VL - 11
IS - 24
SP - 8969S
EP - 8970S
Y2 - 2025/07/27
ER -